Peter A. Nitze, Chief Operating Officer&Exec VP at MARTEK BIOSCIENCES CORP (MATK), bought 1,000 shares at $21.15 ($21K) on 2007-04-04, disclosed to the SEC on 2007-04-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.